The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Role of Phytochemicals in Cancer Chemoprevention: Insights
Open accessAbstract
Cancer is a condition where the body cells multiply in an uncontrollable manner. Chemoprevention of cancer is a broad term that describes the involvement of external agents to slow down or suppress cancer growth. Synthetic and natural compounds are found useful in cancer chemoprevention. The occurrence of global cancer type varies, depending on many factors such as environmental, lifestyle, genetic etc. Cancer is often preventable in developed countries with advanced treatment modalities, whereas it is a painful death sentence in developing and low-income countries due to the lack of modern therapies and awareness. One best practice to identify cancer control measures is to study the origin and risk factors associated with common types. Based on these factors and the health status of patients, stage, and severity of cancer, type of treatment is decided. Even though there are well-established therapies, cancer still stands as one of the major causes of death and a public health burden globally. Research shows that most cancers can be prevented, treated, or the incidence can be delayed. Phytochemicals from various medicinal plants were reported to reduce various risk factors associated with different types of cancer through their chemopreventive role. This review highlights the role of bioactive compounds or natural products from plants in the chemoprevention of cancer. There are many plant based dietary factors involved in the chemoprevention process. The review discusses the process of carcinogenesis and chemoprevention using plants and phytocompounds, with special reference to five major chemopreventive phytocompounds. The article also summarizes the important chemopreventive mechanisms and signaling molecules involved in the process. Since the role of antioxidants in chemoprevention is inevitable, an insight into plant-based antioxidant compounds that fight against this dreadful disease at various stages of carcinogenesis and disease progression is discussed. This will fill the research gap in search of chemopreventive natural compounds and encourage scientists in clinical trials of anticancer agents from plants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kalra, N., Seth, K., Prasad, S., Singh, M., Pant, A. B., & Shukla, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.009 · Cited by 50
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
PI3K/AKT/mTOR Pathway in Angiogenesis
Karar, J., & Maity, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00051 · Cited by 1,461
The Hedgehog and Wnt signalling pathways in cancer
Taipale, J., & Beachy, P. A. (2001) · Nature · doi:10.1038/35077219 · Cited by 1,393
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
The MAPK pathway across different malignancies: A new perspective
Burotto, M., Chiou, V. L., Lee, J., & Kohn, E. C. (2014) · Cancer · doi:10.1002/cncr.28864 · Cited by 956
Free radical-induced damage to DNA: mechanisms and measurement
Dizdaroglu, M., Jaruga, P., Birincioglu, M., & Rodriguez, H. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00826-2 · Cited by 953
The therapeutic potential of resveratrol: a review of clinical trials
Berman, A. Y., Motechin, R. A., Wiesenfeld, M. Y., & Holz, M. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0038-6 · Cited by 888
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Dietary Flavonoids and the Risk of Lung Cancer and Other Malignant Neoplasms
Knekt, P., J rvinen, R., Sepp nen, R., Heli vaara, M., Teppo, L., Pukkala, E., & Aromaa, A. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009257 · Cited by 771
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
Ramos, S. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700326 · Cited by 696
Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention
Ramos, S. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.11.004 · Cited by 617
Dixon, R. (2002) · Phytochemistry · doi:10.1016/s0031-9422(02)00116-4 · Cited by 609
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment
Chikara, S., Nagaprashantha, L. D., Singhal, J., Horne, D., Awasthi, S., & Singhal, S. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.002 · Cited by 559
Resveratrol: A multitargeted agent for age-associated chronic diseases
Harikumar, K. B., & Aggarwal, B. B. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5740 · Cited by 550
Intake of Flavonoids and Lung Cancer
Le Marchand, L., Murphy, S. P., Hankin, J. H., Wilkens, L. R., & Kolonel, L. N. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.154 · Cited by 550
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Bishayee, A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0160 · Cited by 528
Fujiki, H. (1986) · PubMed · Cited by 527
Peterson, G., & Barnes, S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91423-a · Cited by 466
Yang, J., Pi, C., & Wang, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.072 · Cited by 450
Approaches to prevention of epithelial cancer during the preneoplastic period.
Sporn, M. B. (1976) · PubMed · Cited by 445
Saiko, P., Szakmary, A., Jaeger, W., & Szekeres, T. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.08.004 · Cited by 442
Okura, A., Arakawa, H., Oka, H., Yoshinari, T., & Monden, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80030-5 · Cited by 437
Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., & Savouret, J.-F. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12541-2 · Cited by 416
Bagchi, D., Sen, C. K., Bagchi, M., & Atalay, M. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000016355.19999.93 · Cited by 404
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
Kotecha, R., Takami, A., & Espinoza, J. L. (2016) · Oncotarget · doi:10.18632/oncotarget.9593 · Cited by 396
Evans, B. A. J., Griffiths, K., & Morton, M. S. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470295 · Cited by 385
Nandakumar, V., Vaid, M., & Katiyar, S. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq285 · Cited by 368
Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M., & Aggarwal, B. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206048 · Cited by 353
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Mereles, D., & Hunstein, W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095592 · Cited by 325
Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients
Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., & Higashi, Y. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00556.x · Cited by 303
González-Vallinas, M., González-Castejón, M., Rodríguez-Casado, A., & Ramírez de Molina, A. (2013) · Nutrition Reviews · doi:10.1111/nure.12051 · Cited by 302
Jatoi, A., Ellison, N., Burch, P. A., Sloan, J. A., Dakhil, S. R., Novotny, P., Tan, W., Fitch, T. R., Rowland, K. M., Young, C. Y. F., et al. (2003) · Cancer · doi:10.1002/cncr.11200 · Cited by 284
Ciolino, H. P., Daschner, P. J., & Yeh, G. C. (1998) · PubMed · Cited by 283
Chen, C., & Kong, A.-N. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.004 · Cited by 273
Overview of mechanisms of cancer chemopreventive agents
De Flora, S., & Ferguson, L. R. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.029 · Cited by 272
Cancer therapy with phytochemicals: evidence from clinical studies.
Hosseini, A., & Ghorbani, A. (2015) · Europe PMC (PubMed Central) · Cited by 271
Gupta, S., Afaq, F., & Mukhtar, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5672 · Cited by 269
A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells
Dhawan, P., & Richmond, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112210200 · Cited by 267
Valcic, S., Timmermann, B. N., Alberts, D. S., W??chter, G. A., Krutzsch, M., Wymer, J., & Guill??n, J. M. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199606000-00011 · Cited by 267
Soya foods and breast cancer risk: A prospective study in Hiroshima and Nagasaki, Japan
Key, T. J., Sharp, G. B., Appleby, P. N., Beral, V, Goodman, M. T., Soda, M., & Mabuchi, K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690837 · Cited by 262
Afaq, F., Adhami, V. M., & Ahmad, N. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00014-5 · Cited by 262
New Perspectives of Curcumin in Cancer Prevention
Park, W., Amin, A. R. M. R., Chen, Z. G., & Shin, D. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0410 · Cited by 260
Green Tea Flavan-3-ols: Colonic Degradation and Urinary Excretion of Catabolites by Humans
Roowi, S., Stalmach, A., Mullen, W., Lean, M. E. J., Edwards, C. A., & Crozier, A. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9032975 · Cited by 257
Malik, F., Kumar, A., Bhushan, S., Khan, S., Bhatia, A., Suri, K. A., Qazi, G. N., & Singh, J. (2007) · Apoptosis · doi:10.1007/s10495-007-0129-x · Cited by 254
Nielsen, S. E., Young, J. F., Daneshvar, B., Lauridsen, S. T., Knuthsen, P., Sandström, B., & Dragsted, L. O. (1999) · British Journal of Nutrition · doi:10.1017/s000711459900080x · Cited by 254
Molecular mechanisms of anti-angiogenic effect of curcumin
Gururaj, A. E., Belakavadi, M., Venkatesh, D. A., Marmé, D., & Salimath, B. P. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02306-9 · Cited by 253
Cellular signaling perturbation by natural products
Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.03.009 · Cited by 248
Phase I Trial of Oral Green Tea Extract in Adult Patients With Solid Tumors
Pisters, K. M. W., Newman, R. A., Coldman, B., Shin, D. M., Khuri, F. R., Hong, W. K., Glisson, B. S., & Lee, J. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1830 · Cited by 243
In vitro and in vivo anti-tumor effects of Astragalus membranaceus
Cho, W. C. S., & Leung, K. N. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.001 · Cited by 239
Cancer chemoprevention with garlic and its constituents
Shukla, Y., & Kalra, N. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.05.009 · Cited by 239
Feng, R., Ni, H.-M., Wang, S. Y., Tourkova, I. L., Shurin, M. R., Harada, H., & Yin, X.-M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610616200 · Cited by 238
Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy
Sung, B., Chung, H. Y., & Kim, N. D. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.4.216 · Cited by 236
Cancer prevention – the potential for diet to modulate molecular signalling
Manson, M. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00002-3 · Cited by 231
Inhibition of cancer cell invasion and metastasis by genistein
Pavese, J. M., Farmer, R. L., & Bergan, R. C. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9238-z · Cited by 230
Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38
Granado-Serrano, A. B., Martín, M. A., Bravo, L., Goya, L., & Ramos, S. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.12.005 · Cited by 224
Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., Marian, B., Lichtenberg, D., & Arber, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0171 · Cited by 221
Yang, C.-L., Liu, Y.-Y., Ma, Y.-G., Xue, Y.-X., Liu, D.-G., Ren, Y., Liu, X.-B., Li, Y., & Li, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037960 · Cited by 220
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Aziz, M. H., Reagan‐Shaw, S., Wu, J., Longley, B. J., & Ahmad, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3582fje · Cited by 220
Absorption, metabolism and excretion of Choladi green tea flavan‐3‐ols by humans
Stalmach, A., Troufflard, S., Serafini, M., & Crozier, A. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800169 · Cited by 218
Multitargeted therapy of cancer by lycopene
van Breemen, R. B., & Pajkovic, N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.016 · Cited by 215
Adhami, V. M., Afaq, F., & Ahmad, N. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80019-2 · Cited by 209
Tattelman, E. (2005) · PubMed · Cited by 200
Li, Y., Yuan, Y.-Y., Meeran, S. M., & Tollefsbol, T. O. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-274 · Cited by 199
Pérez-Ruiz, E., Melero, I., Kopecka, J., Sarmento-Ribeiro, A. B., García-Aranda, M., & De Las Rivas, J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100718 · Cited by 196
Schindler, R., & Mentlein, R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1477 · Cited by 193
Antioxidants: Scientific Literature Landscape Analysis
Yeung, A. W. K., Tzvetkov, N. T., El-Tawil, O. S., Bungǎu, S. G., Abdel-Daim, M. M., & Atanasov, A. G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8278454 · Cited by 189
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Shukla, S., Bhaskaran, N., Babcook, M. A., Fu, P., MacLennan, G. T., & Gupta, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt316 · Cited by 188
Jagetia, G. C., & Rao, S. K. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.460 · Cited by 185
Cohen, S. M., & Arnold, L. L. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq365 · Cited by 179
Wang, X., Bai, H., Zhang, X., Liu, J., Cao, P., Liao, N., Zhang, W., Wang, Z., & Hai, C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt058 · Cited by 178
Wattenberg, L. W. (1996) · Preventive Medicine · doi:10.1006/pmed.1996.0015 · Cited by 177
Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., Savouret, J., & Casper, R. F. (2003) · Journal of Applied Toxicology · doi:10.1002/jat.916 · Cited by 174
Kim, J.-D., Liu, L., Guo, W., & Meydani, M. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.06.006 · Cited by 173
Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health Study
Cutler, G. J., Nettleton, J. A., Ross, J. A., Harnack, L. J., Jacobs, D. R., Scrafford, C. G., Barraj, L. M., Mink, P. J., & Robien, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23564 · Cited by 173
Phytoestrogens: End of a tale?
Sirtori, C. R., Arnoldi, A., & Johnson, S. K. (2005) · Annals of Medicine · doi:10.1080/07853890510044586 · Cited by 173
De Sousa, O. V., Vieira, G. D.-V., De Pinho, J. D. J. R. G., Yamamoto, C. H., & Alves, M. S. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11052067 · Cited by 173
Wu, W.-S., Wu, J.-R., & Hu, C.-T. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9112-4 · Cited by 171
Hastak, K., Agarwal, M. K., Mukhtar, H., & Agarwal, M. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2226fje · Cited by 171
Arts, I. C. W., Jacobs, D. R., Gross, M., Harnack, L. J., & Folsom, A. R. (2002) · Cancer Causes & Control · doi:10.1023/a:1015290131096 · Cited by 170
Annabi, B., Lachambre, M.-P., Bousquet-Gagnon, N., Pagé, M., Gingras, D., & Béliveau, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00187-2 · Cited by 165
Zanotto-Filho, A., Braganhol, E., Edelweiss, M. I., Behr, G. A., Zanin, R., Schröder, R., Simões-Pires, A., Battastini, A. M. O., & Moreira, J. C. F. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.02.015 · Cited by 164
Wung, B., Hsu, M. C., Wu, C., & Hsieh, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.052 · Cited by 160
Reagan-Shaw, S., Afaq, F., Aziz, M. H., & Ahmad, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207666 · Cited by 158
Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights
Farooqı, A. A., de la Roche, M., Djamgoz, M. B. A., & Siddik, Z. H. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.01.001 · Cited by 158
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Lin, C.-H., Chang, C.-Y., Lee, K., Lin, H.-J., Chen, T.-H., & Wan, L. (2015) · BMC Cancer · doi:10.1186/s12885-015-1965-7 · Cited by 157
Vitamin A, Cancer Treatment and Prevention: The New Role of Cellular Retinol Binding Proteins
Doldo, E., Costanza, G., Agostinelli, S., Tarquini, C., Ferlosio, A., Arcuri, G., Passeri, D., Scioli, M. G., & Orlandi, A. (2015) · BioMed Research International · doi:10.1155/2015/624627 · Cited by 156
Luo, H., Tang, L., Tang, M. X., Billam, M., Huang, T., Yu, J., Wei, Z., Liang, Y., Wang, K., Zhang, Z., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi147 · Cited by 156
Resveratrol Role in Autoimmune Disease—A Mini-Review
Oliveira, A., Monteiro, V. S., Navegantes-Lima, K. C., Reis, J. F., Gomes, R. D. S., Rodrigues, D. V. S., Gaspar, S. L. D. F., & Monteiro, M. C. (2017) · Nutrients · doi:10.3390/nu9121306 · Cited by 154
Genistein inhibits protein histidine kinase.
Huang, J., Nasr, M. L., Kim, Y., & Matthews, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49564-1 · Cited by 153
Vazhappilly, C. G., Kumar, D. R. N., Rajkumar, V., Suresh, P. K., & Kumar, R. A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.699 · Cited by 153
Sun, Z., Chen, G., Hu, X., Zhang, W., Liu, Y., Zhu, L., Zhou, Q., & Zhao, Y. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0497-5 · Cited by 152
The research and development on the antioxidants in prevention of diabetic complications
Rahimi‐Madiseh, M., Malekpour-Tehrani, A., Bahmani, M., & Rafieian‐Kopaei, M. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.001 · Cited by 150
Sharma, G. D., Tyagi, A. K., Singh, R. P., Chan, D. C. F., & Agarwal, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000020991.55659.59 · Cited by 146
Aziz, M. H., Afaq, F., & Ahmad, N. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-08-13-ra-274.1 · Cited by 146
Alam, M. N., Almoyad, M. A. A., & Huq, F. (2018) · BioMed Research International · doi:10.1155/2018/4154185 · Cited by 146
Zhou, Y., & Lee, A. S. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.5.381 · Cited by 143
Semisynthesis and in vitro anticancer activities of andrographolide analogues
Jada, S. R., Subur, G. S., Matthews, C., Hamzah, A. S., Lajis, N. H., Saad, M. S., Stevens, M. F. G., & Stanslas, J. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.11.031 · Cited by 138
Retinoids and breast cancer: From basic studies to the clinic and back again
Garattini, E., Bolis, M., Garattini, S. K., Fratelli, M., Centritto, F., Paroni, G., Gianni’, M., Zanetti, A., Pagani, A., Fisher, J. N., et al. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.01.001 · Cited by 138
PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Gasparri, M. L., Bardhi, E., Ruscito, I., Papadia, A., Farooqı, A. A., Marchetti, C., Bogani, G., Ceccacci, I., Mueller, M. D., & Panici, P. B. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0043-118907 · Cited by 136
Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy4
Auger, C., Mullen, W., Hara, Y., & Crozier, A. (2008) · Journal of Nutrition · doi:10.1093/jn/138.8.1535s · Cited by 135
Bhushan, S., Singh, J., Madhusudana, R. J., Kumar, S. A., & Nabi, Q. G. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.09.009 · Cited by 133
Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound
Labrecque, L. G. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi024 · Cited by 132
Mahmoud, A. M., Mohammed, H. M., Khadrawy, S. M., & Galaly, S. R. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.09.015 · Cited by 129
Park, C., Jin, K.-S., Lee, Y.-W., & Song, Y.-S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.007 · Cited by 122
Lewińska, A., Adamczyk‐Grochala, J., Kwasniewicz, E., Deręgowska, A., & Wnuk, M. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1353-7 · Cited by 122
Plant-derived epigenetic modulators for cancer treatment and prevention
Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.03.009 · Cited by 118
Kim, H. S., Kim, M. H., Jeong, M. H., Hwang, Y. S., Lim, S. H., Shin, B. A., Ahn, B. W., & Jung, Y. D. (2004) · PubMed · Cited by 114
Yoon, H. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.966 · Cited by 113
Bimonte, S., Barbieri, A., Palma, G., Luciano, A., Rea, D., & Arra, C. (2013) · BioMed Research International · doi:10.1155/2013/810423 · Cited by 113
Wu, Q. K., Koponen, J. M., Mykkänen, H. M., & Törrönen, A. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062320t · Cited by 112
Su, L. J., & Arab, L. (2002) · Public Health Nutrition · doi:10.1079/phn2001314 · Cited by 107
Apigenin blocks IKKα activation and suppresses prostate cancer progression
Shukla, S., Kanwal, R., Shankar, E., Datt, M., Chance, M. R., Fu, P., MacLennan, G. T., & Gupta, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5157 · Cited by 107
Prakobwong, S., Khoontawad, J., Yongvanit, P., Pairojkul, C., Hiraku, Y., Sithithaworn, P., Pinlaor, P., Aggarwal, B. B., & Pinlaor, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25656 · Cited by 106
Oh, S., Gwak, J., Park, S., & Yang, C. S. (2014) · BioFactors · doi:10.1002/biof.1185 · Cited by 105
Zhang, X., Zhang, H., Tighiouart, M., Lee, J. E., Shin, H. J. C., Khuri, F. R., Yang, C. S., Chen, Z., & Shin, D. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23585 · Cited by 105
Cancer Chemoprevention: Current State of the Art
Landis‐Piwowar, K. R., & Iyer, N. R. (2014) · Cancer Growth and Metastasis · doi:10.4137/cgm.s11288 · Cited by 105
Kang, S. S., Palau, V. E., Lightner, J., Chakraborty, K., Stone, W. L., Campbell, S., Reddy, S. A. G., & Krishnan, K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.008 · Cited by 102
Yu, M., Xue, J., Li, Y., Zhang, W., Ma, D., Liu, L., & Zhang, Z. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1026-4 · Cited by 100
Souza, R. P., Mendonca, P., Gimenes, F., Ratti, B. A., Kaplum, V., Bruschi, M. L., Nakamura, C. V., Silva, S. D. O., Maria–Engler, S. S., & Consolaro, M. E. L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1512745 · Cited by 100
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis
Hahm, E., Gho, Y. S., Park, S., Park, C., Kim, K., & Yang, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.119 · Cited by 99
Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis
Favot, L., Martin, S., Keravis, T. M., Andriantsitohaina, R., & Lugnier, C. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00433-4 · Cited by 96
Antiinflammatory Action of EGCG, the Main Component of Green Tea, through STAT‐1 Inhibition
Tedeschi, E., Suzuki, H., & Menegazzi, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04678.x · Cited by 96
Tsai, J., Hsu, L., Lin, C., Hong, H.-M., Pan, M., Way, T., & Chen, W. J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.07.019 · Cited by 96
Adachi, S., Shimizu, M., Shirakami, Y., Yamauchi, J., Natsume, H., Matsushima‐Nishiwaki, R., To, S., Weinstein, I. B., Moriwaki, H., & Kozawa, O. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp166 · Cited by 95
Zhu, Y. M., Mao, Y., Chen, H., et al. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-54 · Cited by 94
Martin, S., Favot, L., Matz, R. L., Lugnier, C., & Andriantsitohaina, R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01568-x · Cited by 91
Sen, T., Dutta, A., & Chatterjee, A. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833a4385 · Cited by 91
Phase I study of green tea extract in patients with advanced lung cancer
Laurie, S. A., Miller, V. A., Grant, S. C., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0859-1 · Cited by 91
Sulforaphane inhibits growth of phenotypically different breast cancer cells
Pawlik, A., Hać, A., Kaczyńska, A., Antosiewicz, J., & Herman-Antosiewicz, A. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0499-5 · Cited by 91
Green Tea Polyphenol EGCG Sensing Motif on the 67-kDa Laminin Receptor
Fujimura, Y., Sumida, M., Sugihara, K., Tsukamoto, S., Yamada, K., & Tachibana, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037942 · Cited by 90
Genistein and daidzein: different molecular effects on prostate cancer.
Adjakly, M., Ngollo, M., Boiteux, J., Bignon, Y., Guy, L., & Bernard-Gallon, D. J. (2013) · PubMed · Cited by 90
Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide
Zhang, W., Xue, J., Ge, M., Yu, M., Liu, L., & Zhang, Z. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.09.023 · Cited by 87
Papadimitrakopoulou, V. A., Izzo, J. G., Mao, L., Keck, J. M., Hamilton, D., Shin, D. M., El‐Naggar, A. K., den Hollander, P., Liu, D., Hittelman, W. N., et al. (2001) · PubMed · Cited by 87
Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells
Cho, J.-H., Lee, J.-G., Yang, Y., Kim, J., Ahn, J., Baek, N., Lee, K., & Choi, J. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.019 · Cited by 85
Upadhyay, G., Singh, A. K., Kumar, A., Prakash, O., & Singh, M. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.019 · Cited by 84
Yamakawa, S., Asai, T., Uchida, T., Matsukawa, M., Akizawa, T., & Oku, N. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.03.008 · Cited by 83
The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin
Lai, C., Ho, C., & Pan, M. (2020) · Biomolecules · doi:10.3390/biom10060831 · Cited by 83
Prasad, R., Vaid, M., & Katiyar, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043064 · Cited by 82
Salmani, J. M. M., Zhang, X., Jacob, J. A., & Chen, B. (2017) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(17)30052-3 · Cited by 82
Kim, D., Park, K., Chae, I. G., Kundu, J., Kim, E., Kundu, J. K., & Chun, K. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22353 · Cited by 81
Ryu, M. J., & Chung, H. S. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9806-6 · Cited by 78
Going Green: The Role of the Green Tea Component EGCG in Chemoprevention
Schramm, L. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000142 · Cited by 77
Impact of Quercetin and EGCG on Key Elements of the Wnt Pathway in Human Colon Carcinoma Cells
Pahlke, G., Ngiewih, Y., Kern, M., Jakobs, S., Marko, D., & Eisenbrand, G. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0612530 · Cited by 77
Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells
Thomas, R., & Kim, M. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.114 · Cited by 76
Mafuvadze, B., Liang, Y., Besch-Williford, C. L., et al. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0114-x · Cited by 72
Bhatia, N., Agarwal, C., & Agarwal, R. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_20 · Cited by 71
Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets
Marelli, M. M., Marzagalli, M., Fontana, F., Raimondi, M., Moretti, R. M., & Limonta, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27075 · Cited by 71
Hu, R., & Kong, A. T. (2003) · Nutrition · doi:10.1016/j.nut.2003.09.015 · Cited by 70
Yuan, J.-H., Li, Y., & Yang, X. (2007) · Pharmacology · doi:10.1159/000106447 · Cited by 66
Pettit, G. R., Tan, R., Ichihara, Y., Williams, M. D., Doubek, D. L., Tackett, L. P., Schmidt, J. M., Cerny, R. L., Boyd, M. R., & Hooper, J. N. A. (1995) · Journal of Natural Products · doi:10.1021/np50120a025 · Cited by 63
Ahmad, N., Adhami, V. M., Gupta, S., Cheng, P., & Mukhtar, H. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2704 · Cited by 63
Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols
Constantinou, C., Charalambous, C., & Kanakis, D. N. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01962-1 · Cited by 61
Ghosh, S., Bishayee, K., & Khuda‐Bukhsh, A. R. (2013) · Phytotherapy Research · doi:10.1002/ptr.5107 · Cited by 56
Khan, H. Y., Zubair, H., Ullah, M. F., Ahmad, A., & Hadi, S. M. (2011) · BioMetals · doi:10.1007/s10534-011-9475-9 · Cited by 55
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor
Erker, L. R., Schubert, R., Yakushiji, H., Barlow, C., Larson, D., Mitchell, J. B., & Wynshaw-Boris, A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi181 · Cited by 55
Michl, C., Vivarelli, F., Weigl, J., Nicola, G. R. D., Canistro, D., Paolini, M., Iori, R., & Rascle, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157430 · Cited by 55
Driehuis, E., & Clevers, H. C. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13758 · Cited by 55
Cancer Chemoprevention: Successes and Failures
Patterson, S. L., Maresso, K. C., & Hawk, E. T. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.185389 · Cited by 54
Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway
Sui, Y., Yao, H., Li, S., Jin, L. G., Shi, P., Li, Z., Wang, G., Lin, S., Wu, Y., Li, Y., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1487-z · Cited by 54
Review on cancer and anticancerous properties of some medicinal plants
Sharma, H., Parihar, L., & Parihar, P. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001089 · Cited by 51
Masuda, M., Wakasaki, T., Toh, S., Shimizu, M., & Adachi, S. (2011) · Journal of Oncology · doi:10.1155/2011/540148 · Cited by 50
Huang, C., Jan, R., Kuo, C., Chu, Y., Wang, W., Lee, M., Chen, H., & Hung, C. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01812.x · Cited by 48
Das, L., & Vinayak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099583 · Cited by 47
Inhibition of CYP2C9 by natural products: insight into the potential risk of herb-drug interactions
Wang, K., Gao, Q., Zhang, T., Rao, J., Ding, L., & Qiu, F. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1758714 · Cited by 44
Manna, S., Banerjee, S., Mukherjee, S., Das, S., & Panda, C. K. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0198-2 · Cited by 43
Apigenin Inhibits NNK-Induced Focal Adhesion Kinase Activation in Pancreatic Cancer Cells
Pham, H., Chen, M. F., Takahashi, H., King, J. C., Reber, H. A., Hines, O. J., Pandol, S., & Eibl, G. (2012) · Pancreas · doi:10.1097/mpa.0b013e31824d64d9 · Cited by 43
Malarkey, D. E., Hoenerhoff, M. J., & Maronpot, R. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415759-0.00005-4 · Cited by 42
Kang, S. U., Lee, B., Lee, S., Baek, S. J., Shin, Y. S., & Kim, C. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.07.003 · Cited by 42
Hossain, M. M., Banik, N. L., & Ray, S. K. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.033 · Cited by 42
Phytochemicals Attenuating Aberrant Activation of β-Catenin in Cancer Cells
Wang, D., Wise, M. L., Li, F., & Dey, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050508 · Cited by 42
Sikdar, S., Mukherjee, A., Ghosh, S., & Khuda‐Bukhsh, A. R. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.12.004 · Cited by 41
Cordero‐Herrera, I., Martín, M. Á., Bravo, L., Goya, L., & Ramos, S. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.795981 · Cited by 38
Molecularly targeted agents: Their promise as cancer chemopreventive interventions
Thiery-Vuillemin, A., Nguyen, T., Pivot, X. B., Spano, J., Dufresnne, A., & Soria, J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.005 · Cited by 34
Babich, H., Pinsky, S. M., Muskin, E. T., & Zuckerbraun, H. L. (2005) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.09.017 · Cited by 33
Saha, S. K., Sikdar, S., Mukherjee, A., Bhadra, K., Boujedaini, N., & Khuda‐Bukhsh, A. R. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.03.023 · Cited by 31
Mondal, J., Bishayee, K., Panigrahi, A. K., & Khuda‐Bukhsh, A. R. (2014) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(14)60045-5 · Cited by 29
Vézina, A., Chokor, R., & Annabi, B. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1301-x · Cited by 27
Bishayee, K., Paul, A., Ghosh, S., Sikdar, S., Mukherjee, A., Biswas, R., Boujedaini, N., & Khuda‐Bukhsh, A. R. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1732-5 · Cited by 27
Liu, J., Xu, C., Cai, S., Zhou, Y., Li, J., Jiang, R., & Wang, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6549 · Cited by 27
Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia
Werner, B., Gallagher, R. E., Paietta, E. M., Litzow, M. R., Tallman, M. S., Wiernik, P. H., Slack, J. L., Willman, C. L., Sun, Z., Traulsen, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1210 · Cited by 27
Hematulin, A., Ingkaninan, K., Limpeanchob, N., & Sagan, D. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1871 · Cited by 24
Overcoming chemotherapy resistance with herbal medicines: past, present and future perspectives
Wang, Z., Xie, C., Huang, Y. S., Lam, C. W. K., & Chow, M. S. S. (2013) · Phytochemistry Reviews · doi:10.1007/s11101-013-9327-z · Cited by 20
Bimonte, S., Cascella, M., Schiavone, V., Mehrabi-Kermani, F., & Cuomo, A. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s142475 · Cited by 20
Tsukamoto, S., Yamashita, S., Kim, Y. H., Kumazoe, M., Huang, Y., Yamada, K., & Tachibana, H. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.065 · Cited by 19
Guo, W., Li, L., He, Z.-Y., Zhang, Q., Liu, J., Cui-ying, H., Qin, F.-J., & Wang, T. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6363 · Cited by 17
Zhang, T., Rao, J., Li, W., Wang, K., & Qiu, F. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1828910 · Cited by 17
Cited by
Chaudhary, P., Janmeda, P., Docea, A. O., Yeskaliyeva, B., Abdull Razis, A. F., Modu, B., Calina, D., & Sharifi-Rad, J. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1158198 · Cited by 1,002
Almuntashiri, S. A., Alsubaie, F. F., & Alotaybi, M. (2025) · Cureus · doi:10.7759/cureus.78629 · Cited by 10
Metadata
- Authors
- George, B. P., Chandran, R., & Abrahamse, H.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-09-14
- Volume
- 10
- Issue
- 9
- Pages
- 1455
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3199189658
- Cited by
- 295
- References
- 202
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.